#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Current pharmacotheraupeutical options of lower urinary tract symptoms


Authors: Marcela Fontana
Authors‘ workplace: Urologická klinika 2. LF UK, Praha
Published in: Čes. slov. Farm., 2025; 74, 90-93
Category: Current Pharmacotherapy
doi: https://doi.org/10.36290/csf.2025.012

Overview

Lower urinary tract symptoms (LUTS) represent a wide unit with multifactorial etiology, and therefore, treatment is not uniform. In most patients with LUTS, pharmacotherapy is an effective option for managing these symptoms, thereby improving the quality of life. We have medications from various drug classes available, which can be effectively combined to achieve the best therapeutic outcome. The following text provides an overview of the current pharmacotherapy for LUTS.nce-based medicine principles are essential when searching for and critically evaluating information use in pregnancy.

Keywords:

pharmacotherapy – LUTS – phosphodiesterase 5 inhibitors – lower urinary tract symtoms – α-1 adrenoreceptor antagonists – 5α-reductase inhibitors – muscarinic receptor antagonists – beta-3 agonists


Labels
Pharmacy Clinical pharmacology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#